MedPath

DeepQure Inc.

πŸ‡°πŸ‡·South Korea
Ownership
-
Employees
-
Market Cap
-
Website

Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension

Not Applicable
Recruiting
Conditions
Resistant Hypertension
First Posted Date
2024-07-30
Last Posted Date
2025-03-27
Lead Sponsor
DeepQure Inc.
Target Recruit Count
15
Registration Number
NCT06526858
Locations
πŸ‡ΊπŸ‡Έ

University of California Irvine, Orange, California, United States

πŸ‡ΊπŸ‡Έ

University of Arizona Department of Urology, Tucson, Arizona, United States

πŸ‡ΊπŸ‡Έ

Mayo Clinic, Rochester, Minnesota, United States

and more 2 locations

A First-in-human Study of HyperQureTM", Laparoscopic Renal Denervation Therapy in Patient With Resistant Hypertension

Not Applicable
Recruiting
Conditions
Resistant Hypertension
Interventions
Device: HyperQure Renal Denervation System
First Posted Date
2024-01-22
Last Posted Date
2025-02-10
Lead Sponsor
DeepQure Inc.
Target Recruit Count
10
Registration Number
NCT06216808
Locations
πŸ‡°πŸ‡·

Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

πŸ‡°πŸ‡·

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea, Republic of

πŸ‡°πŸ‡·

Hanyang University Seoul Hospital, Seoul, Korea, Republic of

and more 2 locations
Β© Copyright 2025. All Rights Reserved by MedPath